Loerrach, Germany

Harald Kropshofer

This inventor holds 6 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Maxygen, Inc., Roche Palo Alto LLC. Active years: 2008-2009.



 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2008-2009

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Harald Kropshofer

Introduction

Harald Kropshofer is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of interferon-alpha polypeptides and conjugates. With a total of six patents to his name, Kropshofer's work has had a substantial impact on medical research and therapeutic applications.

Latest Patents

Kropshofer's latest patents focus on interferon-alpha polypeptides and conjugates. These inventions provide novel polypeptides and conjugates, along with nucleic acids encoding these polypeptides. The patents also encompass compositions that include these polypeptides, conjugates, and nucleic acids, as well as methods for their production and use. This innovative work aims to enhance the efficacy of treatments involving interferon-alpha, showcasing Kropshofer's commitment to advancing medical science.

Career Highlights

Throughout his career, Kropshofer has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Maxygen, Inc. and Roche Palo Alto LLC. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kropshofer has collaborated with esteemed colleagues such as Phillip A Patten and Sridhar Viswanathan. These partnerships have facilitated the exchange of ideas and expertise, further enriching his contributions to the field of biotechnology.

Conclusion

Harald Kropshofer's innovative work in the development of interferon-alpha polypeptides and conjugates highlights his significant role in advancing medical research. His six patents reflect a dedication to improving therapeutic options and underscore the importance of collaboration in scientific progress.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…